Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Medigen Vaccine Biologics Corp. (6547) Financial Statements

Medigen Vaccine Biologics Corp. Financial Overview

Medigen Vaccine Biologics Corp.'s market cap is currently NT$16.94B. The company's EPS TTM is NT$-0.51; its P/E ratio is -409.93; Medigen Vaccine Biologics Corp. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 613.17MNT$ 605.64MNT$ 389.62MNT$ 365.04MNT$ 3.28B
Gross ProfitNT$ 364.67MNT$ 396.42MNT$ 230.22MNT$ -212.60MNT$ 2.31B
Operating IncomeNT$ -265.69MNT$ -145.67MNT$ -1.21BNT$ -1.45BNT$ 1.42B
EBITDANT$ -123.90MNT$ 74.86MNT$ -991.09MNT$ -1.32BNT$ 1.53B
Net IncomeNT$ -281.71MNT$ -80.47MNT$ -1.16BNT$ -1.50BNT$ 1.41B
Balance Sheet
Cash & Short-Term InvestmentsNT$ 1.78BNT$ 1.92BNT$ 3.76BNT$ 4.24BNT$ 2.23B
Total AssetsNT$ 3.93BNT$ 4.36BNT$ 6.09BNT$ 7.35BNT$ 5.30B
Total DebtNT$ 283.44MNT$ 338.96MNT$ 1.97BNT$ 1.98BNT$ 187.58M
Net DebtNT$ -308.60MNT$ -376.65MNT$ 581.33MNT$ 770.98MNT$ -1.19B
Total LiabilitiesNT$ 454.64MNT$ 513.92MNT$ 2.25BNT$ 2.32BNT$ 622.95M
Stockholders' EquityNT$ 3.48BNT$ 3.85BNT$ 3.85BNT$ 5.03BNT$ 4.68B
Cash Flow
Free Cash FlowNT$ -99.72MNT$ 5.77MNT$ -519.29MNT$ -1.24BNT$ 444.92M
Operating Cash FlowNT$ -49.09MNT$ 40.75MNT$ -478.33MNT$ -1.10BNT$ 579.89M
Investing Cash FlowNT$ -35.30MNT$ 1.02BNT$ 669.83MNT$ -2.40BNT$ -930.69M
Financing Cash FlowNT$ -39.19MNT$ -1.74BNT$ 1.59MNT$ 3.32BNT$ 51.18M

Currency in TWD

Medigen Vaccine Biologics Corp. Earnings and Revenue History

-2B02B4B-60000 %-30000 %0 %30000 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Medigen Vaccine Biologics Corp. Liabilities to Assets

03B6B9B0 %15 %30 %45 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Medigen Vaccine Biologics Corp. Cash Flow

-3B-2B-1B01B2B3B4B201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Medigen Vaccine Biologics Corp. Forecast EPS vs Actual EPS

-0.6-0.4-0.200.20.40.6Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >